G. Dom, Belgium

Antwerp University Psychiatry
Geert Dom is a full professor of psychiatry at the Medical Faculty, Psychiatry Department of the Antwerp University and vice-chair of the Collaborative Antwerp Psychiatric Research Institute (CAPRI), Antwerp Belgium, Belgium. In addition he is the Medical Director of the psychiatric Hospital Multiversum, Antwerp region, Belgium. His research and teaching focuses on Addiction-Psychiatry (bibliography: https://anet.ua.ac.be/desktop/irua). He is European Psychiatric Association (EPA) board member and Treasurer and chair of the EPA section on Addictive Behaviors. In addition he is the current president of the European Federation of Addiction Societies (EUFAS; http://www.eufas.net ) and the Belgian Professional Society of Medical Specialists in Psychiatry.

Moderator Of 5 Sessions

Date
Tue, 13.04.2021
Session Time
17:00 - 17:30
Room
EPA TV
Chair(s)
Session Icon
Live TV
Clinical/Therapeutic
Date
Sun, 11.04.2021
Session Time
10:00 - 11:30
Room
Channel 7
Session Description
The Live Q&A of this session will take place in the Live Sessions auditorium. Please refer to the interactive programme for the exact time and channel.

Proposed by the EPA section on Addictive Behaviours -Patients with psychiatric disorders and co-occurring addictive disorders often pose a clinical challenge, both in the diagnostic process, as well as during treatment. Co-occurring substance use may interfere with clinical assessment and often requires adjustment of pharmacological and psychological treatment approaches. However, comorbidity between psychiatric disorders and addictive disorders is rather common with about 30% of cases also having a substance use disorder, depending on the type of psychiatric condition and treatment setting. As a result, every clinician working in psychiatry will encounter clinical dilemma’s as described above. In this symposium, experts in the field co-occurring addictive disorders in psychosis, bipolar disorder, suicidal behavior and ADHD will share clinical dilemma’s and scientific answers to these dilemma’s. With this symposium, the speakers intend to provide tools and advice to come to more personalized and integrated treatment for your patients. Speakers will share data, recent literature and their view on diagnosis and treatment in patients with psychosis, bipolar disorder, suicidal behavior and ADHD. All speakers are connected to the Network of Early Career Professionals working in the area of Addiction Medicine (NECPAM: http://necpam.co/).

Session Icon
Pre-Recorded with Live Q&A, Section
Clinical/Therapeutic
Date
Mon, 12.04.2021
Session Time
10:00 - 11:30
Room
Channel 3
Session Description
Proposed by the EPA section on Addictive Behaviours - Rational strategies for the transfer of innovative drug targets from animal lab to clinical routine are still scarce in research and treatment of alcohol addiction. Drug development has been shown to be successful if innovative pathways are targeted in pre-clinical studies, but only if it is additionally accompanied by an innovative clinical treatment regime. In order to foster discussion and to define requirements regarding treatment targets, translationally applicable read-outs, and useful interventions we have assembled an expert group that will introduce novel concepts of innovative treatment targets and recent treatment strategies in alcohol-use disorders. Anne R Lingford-Hughes will present an overview on the neurobiological basis of alcohol addiction and principles of relapse prevention treatment; especially those that aim to reduce reward anticipation. The role of oxytocin neurotransmitter systems in addictive behaviour with a focus on recent imaging genetics studies will be the topic of the talk of Patrick Bach in order to define it as a potential future treatment target. Lofti Khemiri agreed to present data of a recently finished project focussing on the role of cognitive function in relapse prevention and associated pharmacological treatment options. At least Benjamin Rolland presents data on the experiences with baclofen in AUD treatment in France highlighting the difficult interpenetration between evidence-based medicine on the one hand, and on-the-ground practice on the other hand.
Session Icon
Live, Section
Clinical/Therapeutic
Date
Sun, 11.04.2021
Session Time
17:30 - 18:15
Room
Channel 1
Chair(s)
Session Icon
Live
Date
Sun, 11.04.2021
Session Time
13:00 - 13:30
Room
EPA TV
Chair(s)
Session Icon
Live TV

Presenter Of 5 Presentations

Tuesday, 13 April: Highlights of the Day (ID 1172) No Topic Needed

Highlights of the Day

Session Icon
Live TV
Date
Tue, 13.04.2021
Session Time
17:00 - 17:30
Room
EPA TV
Lecture Time
17:00 - 17:30
Symposium: Improving Care for Patients with Co-occurring Addictive Disorders Through Personalised and Integrated Addiction Psychiatry (ID 289) No Topic Needed
LIVE - Symposium: Novel Pharmacotherapeutic Strategies for Regaining Control over Alcohol Intake in Alcohol Use Disorder (ID 336) No Topic Needed
LIVE - State of the Art: Digital Interventions in Severe Mental Disorders (ID 602) No Topic Needed

Live Q&A

Session Icon
Live
Date
Sun, 11.04.2021
Session Time
17:30 - 18:15
Room
Channel 1
Lecture Time
17:55 - 18:15
Sunday, 11 April: Midday Roundup (ID 1164) No Topic Needed

Midday Roundup

Session Icon
Live TV
Date
Sun, 11.04.2021
Session Time
13:00 - 13:30
Room
EPA TV
Lecture Time
13:00 - 13:30